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Abstract 
Tissue engineering creates biological tissues that aim to improve the function of diseased or damaged tissues such as the cornea 
(the main refractive component of the eye). Traditional tissue engineering strategies employ a ‘‘top-down’’ approach, in which 
cells are seeded on a polymeric scaffold that they then populate and create the appropriate extracellular matrix (ECM) often with 
the aid of perfusion, growth factors and/or mechanical stimulation. However, in highly organised tissues, such as the cornea, top-
down approaches have difficulty recreating intricate but necessary microstructural features.  
With the desire to create more complex corneal tissues with features such as anisotropic hierarchical molecular assemblies, 
appropriate mechanical properties, cell binding motifs and corneal specific morphology, we are developing tissue engineering 
techniques that are moving away from the traditional top-down approach and instead focusing on building modular micro-tissues 
with repeated functional units which facilitate a bottom-up approach. 
Here we report on the success and shortcomings of both top-down and bottom-up approaches to creating engineered corneal 
tissues. Specifically, we will discuss recent work demonstrating the importance of engineering corneal ECM with appropriate 
levels of tissue compliance using a top-down approach. We will then highlight a bottom-up approach, which focuses on 
fabricating discreet bio-prosthetic ECM building blocks (corneal lamellae) with specific micro-architectural features derived 
solely from human corneal keratocytes under serum free conditions using enzyme responsive templates. These building blocks 
will then be used to generate a whole cornea whilst maintaining the intricate architecture and complexity of native corneal ECM. 
© 2015 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of IDMEC-IST. 
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1. Introduction 
The cornea is the main refractive part of the eye responsible for over 75% of light transmission to the retina thus 
enabling vision [1]. The cornea is transparent and comprised of three cellular layers: an outermost epithelium, a 
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middle stroma and an innermost endothelium [2-3]. Although highly innervated, the cornea is avascular and 
immunologically privileged.  
According to the World Health Organization, “diseases affecting the cornea are a major cause of blindness 
worldwide, second only to cataract in overall importance” [4] and allograft cornea transplantation remains the most 
common treatment.  However, the supply of high quality donor cornea worldwide falls well short of demand, 
moreover they present a low but genuine risk of disease transmission, largely circumvented by expensive screening 
procedures ($2,500 - $3,500 USD per cornea) [5]. These complications are compounded by the growing use of 
corrective eye surgery, which renders these corneas unsuitable for grafting, further reducing the availability of 
acceptable allogeneic supplies [6]. As such the replacement of allograft tissue has become a growing topic of 
interest, and there have been many versions of artificial replacements loosely grouped under “artificial corneas” that 
have been developed. These range from prostheses, known as keratoprostheses (KPro) to regenerative medicine 
approaches which typically combine cells with transparent materials but also include decellularized corneas. 
The concept of the artificial corneal substitute was introduced in 1789 by Guillaume Pellier de Quengsy as a 
keratoprosthesis (Kpro) with a porous prosthetic skirt [7]. This design proved to be fundamental to artificial cornea 
research and is currently the model used for the Chirila Kpro, AlphaCorTM [8-11], one of the most clinically 
successful corneal substitutes. The biocompatibility of the microporous skirt material is key to the success of Kpro in 
repairing the cornea. Such microporous materials include poly(2-hydroxyethyl methacrylate) [11,12], porous nano-
hydroxyapatite/poly [13-16] and collagen hydrogels [17-29] each ensuring improved biocompatibility of Kpro. 
Collagen hydrogels, in particular, have replaced less biocompatible materials used for the construction of 
biocompatible Kpro skirt.   
Collagen type I, the most abundant stromal protein in the cornea [30], it is biocompatible, biodegradable and 
possesses low immunogenicity. Therefore hydrogels of collagen type I are particularly attractive as matrix 
replacement scaffolds, partly because of their strength at relatively low concentrations, resulting from the virtually 
rigid rod properties of the collagen type I triple helix [31]. In addition, collagen contains the cell attachment motif 
arginine-glycine-glutamic acid [32]. Collagen hydrogels are, however, unstable and hence require stabilization, e.g. 
by chemical crosslinking [25] or plastic compression [33,34]. Despite the problems associated with collagen gels our 
thesis remains that it is the most appropriate material for corneal tissue engineering. 
Armed with the belief that collagen remains the most suitable material from which corneas can be engineered we 
have explored a number of manufacturing approaches that have been grouped into top-down and bottom-up. In the 
bottom-up approach there are multiple methods for creating modular tissues, which are then assembled into 
engineered tissues with specific microarchitectural features. In the top-down approach, cells and biomaterial 
scaffolds are combined and cultured until the cells fill the support structure to create an engineered tissue. Both 
approaches to corneal tissue engineering are discussed below. 
 
2. Top-down approach to corneal tissue engineering 
Previously we have explored a practical method for enhancing 
the mechanical strength of collagen type-I gels via plastic 
compression, which eliminates the majority of the water content 
from typical, relatively hydrated, collagen gels. By varying 
collagen concentration and compression times, we constructed a 
stronger collagen-based substrate. Specifically, we performed 
controlled, unconfined plastic compression to rapidly produce 
dense, pliable, mechanically-strong collagen scaffolds with 
limited but controllable micro-scale features [26]. In order to 
mimic the normal corneal stroma corneal keratocytes were 
embedded in the collagen scaffold before compression and once 
compressed preserved the cells in a viable cornea-like form 
[24,26] suitable for corneal transplantation [35]. Transparency 
was shown to improve within the construct when embedded 
cells were grown in serum-free media (Fig. 1). Moreover, this 
engineered structure provided an improved substrate capable of 
Figure 1. The transparency of tissue engineered 
constructs developed from compressed collagen 
gels containing human keratocytes can be 
improved by cultivation in serum-free media.  
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supporting the expansion and stratification of corneal epithelial cells. Whilst this top-down approach continues to 
gain much clinical and commercial attention we have subsequently focused more on its application as an in vitro 
model of the corneal stroma. Indeed we have had great success in using this approach to create artificial corneas with 
tractable levels of compliance (tissue stiffness) and subsequently shown that corneal epithelial stem cells are 
sensitive to the compliance of the substrate upon which the reside. Similar to studies using mesenchymal stem cells 
[36] we have shown that that a more compliant substrate maintains the corneal epithelial cells in an undifferentiated 
form and that if subsequently grown on a stiffer (less compliant) surface they readily differentiate [37-39]. The 
biological consequences of this work are only starting to be fully realized. Based on this work we have recently put 
forward the hypothesis that there is a gradient of increasing stiffness centripetally across the cornea and it is this 
change in compliance that drives both the direction of migration as well the differentiation of corneal epithelial cells 
during homeostasis [40]. Moreover the application of this phenomenon is the focus of ongoing regenerative 
medicine research in our lab. 
 
 
3. Bottom-up approach to corneal tissue engineering 
Directing cell behaviour on two-dimensional surfaces so that they perform as if they were in a natural three-
dimensional tissue represents a significant challenge, but one that must be met if the early promise of cell and tissue 
therapy is to be fully realised. The scaling up of cell-based therapies needs to be based on two-dimensional culture 
systems if it is to be commercially viable but it is well understood that the three-dimensional structure of cornea is 
essential for its proper function. While cells on rigid, planar surfaces can respond to the chemical and mechanical 
nature of the ex vivo culture system, they typically have little capacity to reproduce a tissue-specific extracellular 
matrix (ECM). Furthermore, and unlike cultures in three-dimensional matrices (i.e. using top-down approaches), 
cells on flat, non-functionalized surfaces do not exhibit native phenotypes, which consequently affect their ability to 
form higher order structures [41,42]. Therefore, a biomaterial through which one can translate sophisticated two-
dimensional (2D) experimental design into complex cell-derived 3D (hierarchical) structures is of great value to a 
modular, bottom-up approach to corneal tissue engineering. To this end we have recently used RGD(S) peptide 
amphiphiles (PA’s) to coat hydrophobic surfaces composed of striated polytetrafluoroethylene (PTFE) to obtain a 
highly organized tissue, with strict orientation of human cornea stromal fibroblasts (hCSFs) and corresponding 
deposits of extracellular matrix similar to that observed three-dimensionally in vivo [43]. These PA’s have been 
synthesized as self-assembling molecules to obtain supramolecular structures with geometrically-defined nanoscale 
patterns at distinct surface densities, which can be significantly higher than those achieved with intact matrix 
macromolecules [44,45]. The use of supramolecular self-assembly offers the possibility of controlling the structure, 
topography, shape, and dimensions of the 
biomaterial, as well as the spatial display and 
density of the bioactive motifs. This is made 
possible by the local order in the assembled 
nanostructures [44,46]. Previously, several different 
forms of PA nanostructures have been used by us to 
direct stromal cell growth [43, 47-54]. Of particular 
relevance to the bottom-up approach is the use of 
enzyme sensitive RGD-PA [54]. These PA’s also 
form a coating upon which human corneal stromal 
cells (keratocytes) can attach, align and form 
organised collagen structures. However they have 
the additional capability of responding to specific 
endogenous proteases. Once the cells have been 
directed to form an organised collagenous corneal 
matrix of up to 10μm thick, matrix 
metalloproteinase expression is upregulated by 
removal of retinoic acid from the culture media 
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Figure 2. Human keratocytes grown in serum free conditions 
upon a dual functional bioactive peptide amphiphile allows for 
the controlled attachment, stratification and eventual enzyme 
driven release of an engineered tissue. Protease expression is 
controlled by retinoic acid supplementation to the media. 
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[55]. This increased protease expression cleaves the PA between the hydrophilic cell-binding head group and the 
hydrophobic tail of the enzyme-responsive PA resulting in the newly formed piece of engineered cornea to become 
free of the 2D surface. These lamellae like constructs are then ready to be stacked to form a corneal tissue with the 
required level of thickness (Fig. 2). 
 
 
4. Conclusions 
There have been significant developments in tissue engineering approaches to replace partial or full thickness 
damaged or diseased corneas. Biomaterials have been developed to assist in these reparative procedures, to restore 
minimal function or to regenerate the cornea to different degrees. We posit that collagen, as the main structural 
component of the cornea, should remain the biomaterial of choice for corneal tissue engineering. We have 
demonstrated that collagen can be used as a direct scaffold on to which cells are seeded (top-down) or it can be 
endogenously produced via application of interactive biomaterials to control the spatiotemporal cell position and 
differentiation (bottom-up). Whilst both approaches have merit the heightened degree of sophistication in both the 
design of the biomaterials used (e.g. enzyme-responsive peptide amphiphiles) and resulting human derived tissue 
equivalent places the bottom-up approach as our preferred choice. Time will tell as to which approach will have the 
greater clinical success, this is likely to be guided more by limitations in bioprocessing and cost-of-goods than by 
degrees of biologically mimicry, which currently separate the resulting tissue engineered corneas. 
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